Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumors × temsirolimus × Clear all

Phase

Phase 1 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

tivozanib 1 temsirolimus 1 Whey Proteins 1 Sunitinib 1 Paclitaxel 1 Nutrition Assessment 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

AVEO Pharmaceuticals, Inc.

Phase NA Terminated

225 enrolled 7 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡